Vivus commercial chief takes a hike after slew of exec exits

Since bungling the launch of obesity drug Qsymia, Vivus ($VVUS) has lost more than half its board, its CFO, two CEOs and 20 staffers. Now, the company's chief commercial officer is following his departed colleagues out the door. Friday, the company said in a regulatory filing that Michael Miller would make his exit on Feb. 14, with CEO Seth Fischer taking over his responsibilities. 8-K | More